Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | See remarks | March 02, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date March 02, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,091 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Sale · Disposed 864 · Balance 13,091 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 5, 2026 01:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 864 | $139.12 | $120,199.68 |
DisclosureSEC source: 0001193125-26-092183 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,091 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001193125-25-300644 · ownership.xml · derivative · entry 3 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,420 Underlying: Common Stock · 3,000 shares Expires 2033-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,000 | $145.22 | $435,660.00 |
DisclosureSEC source: 0001193125-25-300644 · ownership.xml · nonDerivative · entry 2 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,955 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,000 | $93.88 | $281,640.00 |
DisclosureSEC source: 0001193125-25-300644 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 20:44 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 686 | $139.80 | $95,902.80 |
DisclosureSEC source: 0000950170-25-084405 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,955 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:09 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 8,479 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028048 · ownership.xml · derivative · entry 2 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,479 Underlying: Common Stock · 8,479 shares Expires 2035-02-24 F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:09 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028048 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,641 F1 · shares: Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,289 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0000950170-24-094809 · ownership.xml · derivative · entry 4 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,420 Underlying: Common Stock · 4,289 shares Expires 2033-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,289 | $152.20 | $652,785.80 |
DisclosureSEC source: 0000950170-24-094809 · ownership.xml · nonDerivative · entry 3 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,893 F2 · balance_after: Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 4,289 | $93.88 | $402,651.32 |
DisclosureSEC source: 0000950170-24-094809 · ownership.xml · nonDerivative · entry 2 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024. Read SEC document |
| June 05, 2024 Filed Aug 9, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 703 | $135.21 | $95,052.63 |
DisclosureSEC source: 0000950170-24-094809 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,809 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 21:16 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 14,709 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0000950170-23-038643 · ownership.xml · derivative · entry 2 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,709 Underlying: Common Stock · 14,709 shares Expires 2023-08-01 F2 · derivative.exercise_date: The Option vests as to 25% on August 1, 2024 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 21:16 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 9,512 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-038643 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,512 F1 · shares: Includes 9,512 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.